Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.

Biotechnology

New Amsterdam Pharma

New Amsterdam Pharma's headquarters in Naarden, Netherlands

Michael Davidson

David Topper

Michael Marino

M. Ian Somaiya

BJ Jones

Matthew Philippe

Douglas Kling

Marc Ditmarsch

John Kastelein

Wouter Joustra

Nicholas Downing

Sander Van Slootweg

Lou Lange

James N. Topper

Juliette Audet

John Smither

Stephen Nicholls

Ann Marie Navar

Christie Ballantyne

Kosh Ray

Brian Ference

Janneke van der Kamp

The Board and Advisory Team at New Amsterdam Pharma is responsible for guiding the company's strategic direction, overseeing key business decisions, and ensuring successful clinical research and development of cardiometabolic therapies. Composed of board members and clinical advisors, this team provides expert advice, governance, and industry insights to help achieve the company's mission of improving patient care where traditional treatments fall short.

Board and Advisory Team

This department focuses on the translation of scientific research into medical practice, ensuring that medical professionals are informed of the latest advancements and therapies.

Medical Science

This department focuses on developing and optimizing strategies for commercial operations across various sectors.

Commercial Strategy

The Finance Team at NewAmsterdam Pharma manages the company’s financial planning and analysis, budgets, and financial reporting. They support the clinical-stage research and development efforts by ensuring financial efficiency, compliance, and strategic allocation of resources to advance the company's mission of developing innovative cardiometabolic therapies. The team also collaborates closely with other departments to guide financial decisions and foster sustainable growth.

Finance Team

This department oversees and manages partnerships and collaborations to enhance organizational objectives.

Alliance Management

The Clinical Operations team at New Amsterdam Pharma oversees the planning, execution, and management of clinical trials to ensure they are conducted efficiently and in compliance with regulatory requirements. The team collaborates closely with internal and external stakeholders to advance the development of new therapies for cardiometabolic diseases, aiming to bring innovative treatment options to patients.

New Amsterdam Pharma

Org chart

Board & advisors

Teams

Board and Advisory Team

Medical Science

Commercial Strategy

Finance Team

Alliance Management

Clinical Operations

Offices

New Amsterdam Pharma

Org chart

Board & advisors

Teams

Board and Advisory Team

Medical Science

Commercial Strategy

Finance Team

Alliance Management

Clinical Operations

Offices

Related companies